Physician profile
Jeffrey Moore
NPI 1295929248
$13,809.23
in general payments reported to CMS, 2019-2025
42 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $163 · 2021: $12K · 2022: $428 · 2023: $494 · 2024: $606 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981 · Travel and Lodging: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.70 |
| Travel and Lodging | $376.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,092.30 | 2019-2024 | |
| Stryker Corporation | $193.72 | 2020-2025 | Molli, Aequalis Ascend Flex |
| Smith+Nephew, INC. | $191.19 | 2019-2024 | Pico |
| Davol INC. | $134.77 | 2022-2025 | Phasix Mesh |
| Boston Scientific Corporation | $94.38 | 2021-2025 | Varithena Administration Pack, Spyglass Discover |
| Hologic Sales and Service, LLC | $90.18 | 2022-2023 | Trunode, Localizer, Biozorb |
| Merck Sharp & Dohme LLC | $89.86 | 2019-2023 | Lynparza, Keytruda |
| Ethicon US, LLC | $65.94 | 2019-2023 | Echelon Flex |
| Merit Medical Systems INC | $62.68 | 2021-2025 | Savi Scout |
| Abbvie INC. | $61.76 | 2023 | |
| Becton, Dickinson and Company | $53.34 | 2024 | |
| Medtronic, INC. | $43.09 | 2021-2024 | Endurant Iis |
| Olympus America INC. | $35.45 | 2020-2022 | |
| Innocoll Pharmaceuticals Limited | $34.61 | 2022 | |
| Alpha Orthopedic Systems | $32.47 | 2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $31.51 | 2025 | Irrisept |
| Leica Microsystems INC. | $30.04 | 2023 | Neoprobe |
| Heron Therapeutics, INC. | $29.80 | 2021-2022 | |
| Medtronic Vascular, INC. | $29.04 | 2020 | |
| Progenacare Global, LLC | $28.90 | 2023 | |
| W. L. Gore & Associates, INC. | $28.10 | 2024 | Gore Synecor Biomaterial |
| Endomagnetics Ltd | $25.02 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.92 | 2020 | |
| Exact Sciences Corporation | $24.53 | 2023 | |
| Genentech USA, INC. | $22.54 | 2022 | |
| Ambu INC. | $20.55 | 2022 | |
| Braintree Laboratories, INC. | $19.92 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.19 | 2023 | Exparel |
| Hologic INC | $19.12 | 2021 | |
| Lifenet Health | $17.83 | 2024 | Theragenesis Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $16.32 | 2025 | |
| Surmodics, INC. | $16.08 | 2023 | Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Cagent Vascular INC | $15.81 | 2025 | Serrantor |
| Cashflow Solutions, LLC | $15.72 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Tela Bio, INC. | $14.99 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.94 | 2023 | Seglentis |
| Biocompatibles, INC. | $14.69 | 2019 | |
| Bard Peripheral Vascular, INC. | $13.57 | 2022 | |
| Focal Therapeutics, INC. | $13.30 | 2019 | |
| Silk Road Medical, INC. | $11.27 | 2020 | |
| Aroa Biosurgery Incorporated | $9.37 | 2020 | |
| Thd America, INC. | $6.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.